- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Repligen Corporation (RGEN)
Repligen Corporation stock price live, this page displays NASDAQ RGEN stock exchange data. View the RGEN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Repligen Corporation real time stock price chart below.
What Is the Repligen Corporation Stock Price Today?
The Repligen Corporation stock price today is 127.50.
What Is the Stock Symbol for Repligen Corporation?
The stock symbol for Repligen Corporation is ""RGEN.""
What Stock Exchange Does Repligen Corporation Trade On?
Repligen Corporation is listed and trades on the NASDAQ stock exchange.
Is Repligen Corporation a Good Stock to Buy?
Determining whether Repligen Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGEN quote. (ISIN: US7599161095)
What Is the Repligen Corporation Stock Price Today?
The Repligen Corporation stock price today is 127.50.
What Is the Stock Symbol for Repligen Corporation?
The stock symbol for Repligen Corporation is ""RGEN.""
What Stock Exchange Does Repligen Corporation Trade On?
Repligen Corporation is listed and trades on the NASDAQ stock exchange.
Is Repligen Corporation a Good Stock to Buy?
Determining whether Repligen Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGEN quote. (ISIN: US7599161095)
127.50
-1.65(-1.28%)
Closed·
Fair Value
An estimate of a Repligen Corporation's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
126.50
127.50
52 wk Range
95.80
170.00
Unusual trading volume
1/2
Fair Value
An estimate of a Repligen Corporation's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
126.50127.50
52 wk Range
95.80170.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
RGEN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Repligen Corporation's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- Repligen Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Repligen Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Repligen Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Repligen Corporation Company Profile
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Compare RGEN to Peers and Sector
Metrics to compare | RGEN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRGENPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.2x | −0.7x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.0x | 1.6x | 2.6x | |
Price / LTM Sales | 0.0x | 3.2x | 3.3x | |
Upside (Analyst Target) | 0.0% | 62.3% | 37.1% | |
Fair Value Upside | Unlock | 14.7% | 4.7% | Unlock |
People Also Watch
FAQ
What Stock Exchange Does Repligen Corporation Trade On?
Repligen Corporation is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for Repligen Corporation?
The stock symbol for Repligen Corporation is "RGEN."
What Is the Repligen Corporation Market Cap?
As of today, Repligen Corporation market cap is 7.21B.
What Is Repligen Corporation's Earnings Per Share (TTM)?
The Repligen Corporation EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is RGEN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Repligen Corporation Stock Split?
Repligen Corporation has split 0 times.
What is the current trading status of Repligen Corporation (RGEN)?
As of 16 Oct 2025, Repligen Corporation (RGEN) is trading at a price of 127.50, with a previous close of 127.90. The stock has fluctuated within a day range of 126.50 to 127.50, while its 52-week range spans from 95.80 to 170.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.